Compare Cannara Biotech, Inc. with Similar Stocks
Stock DNA
Other Agricultural Products
CAD 172 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.27
-8.19%
1.68
Revenue and Profits:
Net Sales:
27 Million
(Quarterly Results - May 2025)
Net Profit:
4 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
32.31%
0%
32.31%
6 Months
115.0%
0%
115.0%
1 Year
142.25%
0%
142.25%
2 Years
72.0%
0%
72.0%
3 Years
63.81%
0%
63.81%
4 Years
4.24%
0%
4.24%
5 Years
0%
0%
0.0%
Cannara Biotech, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
111.27%
EBIT Growth (5y)
5.71%
EBIT to Interest (avg)
-2.93
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
0.59
Tax Ratio
1.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.58
EV to EBIT
-19.68
EV to EBITDA
-56.04
EV to Capital Employed
1.44
EV to Sales
1.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.30%
ROE (Latest)
-10.12%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Aug 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.24%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - May'25 - QoQ
May'25
Nov'24
Change(%)
Net Sales
27.30
25.10
8.76%
Operating Profit (PBDIT) excl Other Income
0.70
-0.50
240.00%
Interest
1.10
1.20
-8.33%
Exceptional Items
7.30
6.30
15.87%
Consolidate Net Profit
4.10
2.30
78.26%
Operating Profit Margin (Excl OI)
-21.00%
-83.10%
6.21%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Aug'24
Aug'24
Aug'23
Change(%)
Net Sales
81.70
57.30
42.58%
Operating Profit (PBDIT) excl Other Income
-11.60
-4.40
-163.64%
Interest
5.70
5.30
7.55%
Exceptional Items
25.60
21.20
20.75%
Consolidate Net Profit
6.40
6.90
-7.25%
Operating Profit Margin (Excl OI)
-219.10%
-163.90%
-5.52%
USD in Million.
Net Sales
YoY Growth in year ended Aug 2024 is 42.58% vs 60.06% in Aug 2023
Consolidated Net Profit
YoY Growth in year ended Aug 2024 is -7.25% vs 200.00% in Aug 2023
About Cannara Biotech, Inc. 
Cannara Biotech, Inc.
Other Agricultural Products
Cannara Biotech Inc. is a Canada-based vertically integrated cannabis company. The Company’s segments include indoor cannabis operations and electronic commerce retail. The indoor cannabis segment's operations include cultivation, processing and sale of dried cannabis and cannabis derivatives for the Quebec and Canadian market. The Company also operates as an electronic commerce retailer of United States hemp-based cannabidiol (CBD) products for the United States market. Its subsidiaries include Cannara Biotech (Quebec) Inc. and ShopCBD.com Inc.






